Baxter Oncology

Name

Baxter Oncology

Website

https://baxter-oncology.de

Company type

Private

Headcount range

501–1,000 employees

Short description

Baxter Oncology is a privately held German company based in Halle, employing 501-1,000 staff, that provides B2B administration, business development, supply chain, manufacturing, and quality management services to clients in the oncology sector.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Oncology Specialty Pharmaceuticals (HLAIACAA)

akta.pro secondary industry

Oncology & Hematology Pharmaceuticals (HLAIAAAC)

Keywords

• Oncology contract manufacturing
• Pharmaceutical supply chain
• Drug quality management
• Sterile manufacturing services
• Business development services

Headquarters

HQ city

Halle

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Core offering

Baxter Oncology provides administration, business development, supply chain, manufacturing, and quality management services in the oncology pharmaceutical sector. The company appears to operate as a contract manufacturer and operational services partner for oncology drug products, based in Halle, Germany.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Manufacturing Services
• Pharmaceutical Supply Chain Services
• Quality Management Services
• Business Development Services
• Administration Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Recipharm: Recipharm is a European CDMO offering sterile manufacturing and injectable fill-finish services to pharmaceutical sponsors. It directly overlaps with Baxter Oncology's contract manufacturing value proposition and serves a similar sponsor base across Europe.
• Siegfried Holding: Siegfried is a Swiss-headquartered CDMO with sterile fill-finish and API manufacturing for the European pharma market. It is a direct peer to Baxter Oncology given overlapping capabilities in aseptic manufacturing, GMP quality systems, and a comparable mid-sized European footprint.
• Fareva: Fareva is a French-headquartered pharmaceutical CDMO with sterile injectable manufacturing capabilities serving European and global pharma clients. It is comparable to Baxter Oncology in contract manufacturing of sterile dosage forms, particularly injectables.
• Vetter Pharma: Vetter is a German-headquartered CDMO specializing in aseptic fill-finish of injectable pharmaceuticals, including complex biologics and oncology products. It is a direct peer to Baxter Oncology given the shared German base and sterile injectable focus for regulated pharmaceutical sponsors.
• Aenova Group: Aenova is a German-headquartered CDMO with solid, semi-solid, and sterile manufacturing capabilities for the European pharma market. Comparable to Baxter Oncology as a German-rooted CDMO serving pharma sponsors with GMP-compliant manufacturing services.

Broad incumbents

• Catalent: Catalent is a large global CDMO offering sterile fill-finish, including for oncology injectables and biologics. It is comparable to Baxter Oncology as a contract manufacturer serving pharmaceutical sponsors with similar dosage-form capabilities, but at a much broader portfolio scale.
• Lonza Group: Lonza is one of the world's largest CDMOs with significant sterile injectable and biologic manufacturing capacity, including for oncology and high-potency compounds. It competes with Baxter Oncology for outsourced fill-finish and biomanufacturing contracts from European and global sponsors.
• Thermo Fisher Scientific (Patheon): Thermo Fisher's pharma services division (formerly Patheon) is a global CDMO leader in sterile fill-finish and biopharmaceutical manufacturing. It overlaps with Baxter Oncology as a large-scale contract manufacturer competing for the same sponsor contracts.

Emerging players

• WuXi AppTec / WuXi Biologics: WuXi is a global biopharma CDMO with growing sterile injectable and biomanufacturing capacity. It competes with Baxter Oncology for outsourced manufacturing of oncology and biologic therapies, particularly for European and US sponsors seeking diversified geographic supply.

Others

• Baxter International (BioPharma Solutions): Baxter International operates a BioPharma Solutions contract manufacturing business that historically includes the Halle, Germany oncology facility. It is the parent/operating context for Baxter Oncology and the most direct corporate reference point, though its scope extends well beyond oncology.

Market position

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Baxter Oncology